BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Institute of Oncology
X-ORIGINAL-URL:https://www.bricbordeaux.com
X-WR-CALDESC:Évènements pour Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250702T100000
DTEND;TZID=Europe/Paris:20250702T130000
DTSTAMP:20250707T110527Z
CREATED:20250602T095142Z
LAST-MODIFIED:20250707T110527Z
UID:49440-1751450400-1751461200@www.bricbordeaux.com
SUMMARY:Soutenance HDR Thomas MATHIVET
DESCRIPTION:Soutenance de HDR (Habilitation à Diriger la Recherche) en Sciences de la vie et de la santé \nThomas Mathivet Équipe 01 – Laboratoire de biologie tumorale et vasculaire. \n« Les molécules de guidage : de l’angiogenèse à la dynamique stromale et à l’invasion des tumeurs cérébrales » \nMercredi 2 juillet 2025 à 10h \nAmphi BBS\, 2 rue Dr H. Martinot\, Bordeaux (Site Carreire) \nJury \n➢ M Eric CHEVET\, Directeur de recherche\, Biosit\, INSERM – Rapporteur\n➢ Mme Barbara GARMY-SUSINI\, Directrice de recherche\, I2MC\, INSERM – Rapporteure\n➢ Mme Anna-Rita CANTELMO\, Chargée de recherche\, Université de Lille – Rapporteure\n➢ M François MOISAN\, Docteur\, Université de Bordeaux – Examinateur\n➢ M Andreas BIKALVI\, Professeur des universités\, Université de Bordeaux – Examinateur
URL:https://www.bricbordeaux.com/event/soutenance-hdr-thomas-mathivet/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Colloques & séminaires,Séminaires scientifiques
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2025/06/soutenance-hdr-thomas-mathivet-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250704T110000
DTEND;TZID=Europe/Paris:20250704T120000
DTSTAMP:20250522T081608Z
CREATED:20250522T081608Z
LAST-MODIFIED:20250522T081608Z
UID:49385-1751626800-1751630400@www.bricbordeaux.com
SUMMARY:Séminaire invité - Adriano Sabino - 04-07-2025
DESCRIPTION:Pr Adriano Sabino est invité par Vanessa Desplat\, équipe 10\, Cellules souches hématopoïétiques normales et leucémiques. \nTitle: Omics Sciences Applied to the Investigation of Potential Biomarkers and Therapeutic Targets in Acute Leukemias \nPresenter: Prof. Adriano de Paula Sabino – Federal University of Minas Gerais (UFMG)\, Brazil \nBio: Associate Professor at the Federal University of Minas Gerais (UFMG)\, Brazil. Holds a Ph.D. in Pharmaceutical Sciences with postdoctoral training in cancer therapy resistance at Michigan State University. Academic and research expertise in Clinical\, Experimental\, and Molecular Hematology. Research interests encompass cancer biology\, acute and chronic leukemias\, chemotherapy resistance\, molecular and cellular biomarkers\, functional genomics\, proteomics\, metabolomics\, nanobiomaterials\, regenerative medicine\, cell-based therapies\, and the application of bioinformatics to precision medicine. \nAbstract: \nAcute leukemias\, including Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)\, are aggressive hematologic malignancies with high biological heterogeneity and limited predictive tools for therapeutic response and disease progression. In this context\, omics sciences offer powerful strategies to unravel the molecular complexity underlying these diseases and support the identification of new biomarkers and therapeutic targets. \nThis seminar will provide an overview of our translational research efforts combining metabolomics\, clinical peptidomics\, and machine learning. We will discuss the conceptual and methodological foundations for applying mass spectrometry-based omics approaches (LC-MS and MALDI-TOF/MS) to plasma samples\, as well as the integration of artificial intelligence algorithms to enhance biomarker discovery\, risk stratification\, and individualized therapeutic guidance. \nAdditionally\, we present the rationale and design of predictive modeling studies employing clinical and genomic datasets from AML patients. These models\, based on supervised learning techniques\, aim to improve the accuracy of outcome prediction and inform precision oncology strategies. \nOur interdisciplinary approach highlights the potential of integrating systems biology\, data science\, and clinical research to advance personalized medicine in oncohematology. \nKeywords: Acute leukemia\, ALL\, AML\, biomarkers\, omics sciences\, LC-MS\, MALDI-TOF/MS\, machine learning\, precision oncology\, clinical stratification. \n📆 Vendredi 04-07\, 11h \n📌 salle de conférence BBS\, 2 rue Dr Hoffmann Martinot Bordeaux
URL:https://www.bricbordeaux.com/event/seminaire-invite-adriano-sabino-04-07-2025/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Colloques & séminaires,Séminaires scientifiques
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2025/05/seminar-adriano-sabino-2025-07-13.jpg
END:VEVENT
END:VCALENDAR